“Biotech Industry: Differences and Opportunities in France and the U.S.” roundtable invitation
The French American Chamber of Commerce, in partnership with the Office of Science and Technology of the French Embassy in the U.S., invites you to :
BIOTECH INDUSTRY: DIFFERENCES AND OPPORTUNITIES IN FRANCE AND THE U.S.
THURSDAY, JANUARY 24, 2008
From 6:30 pm to 8:30 pm
Location: Genzyme Center
500 Kendall Street
1st floor
Cambridge, MA 02142
The French Biotechnology industry experienced tremendous growth in 2006-2007. Back in 2005, the French industry only had 4 listed companies. Today, that number has grown to 13. As of mid-september 2007, the industry is on pace to set a record in terms of investments in life science companies, with a total of 625 Euro millions invested. This context is favorable for French biotechnology companies that are now establishing activities in the US market. But it is also interesting for US companies or entrepreneurs that are looking to establish presence in France or develop alliances with French Biotech companies.
The January 24 round table will bring key experts and managers of the US and French biotechnology industry together. It will address opportunities and differences in starting and developing a company in France and in the US and will provide perspectives on the financing and market developments in the French Biotech industry.
Guest Speakers:
Mr. Eric Halioua, Senior Manager, Arthur. D. Little Inc., Moderator
Mr. Frederic Chereau, Vice President, Genzyme Corp.
Mr. Bernard Malfroy-Camine, Executive VP, Proteome Systems
Mr. Ronald Renaud, CFO, Idenix Pharmaceuticals
Mr. Al Sokol, Partner, Edwards, Angell, Palmer & Dodge LLP
To register for this event, you can either download the registration form and fax it to (617) 520-2144, or go on to our website at http://www.faccne.org/agenda.shtml and register online.